Nandita is a Managing Director at RA Capital Management. Prior to RA Capital, Nandita was a Managing Director at Novartis Venture Fund (NVF), a life science investment firm affiliated with Novartis, where she led the NVF US team and focused on early stage and company creation investment opportunities. Prior to NVF, she held various positions at Novartis in Business Development and Licensing and as a key member of the Kymriah Global Program Team, helping to bring this novel cell therapy to market. Nandita also held strategic and group head roles in the Novartis Preclinical Investigative Toxicology organization. She received a B.Sc. in Biochemistry and a Ph.D. in Pharmaceutical Sciences from the University of Toronto, Canada.
News
Making progress and achieving milestones to create innovative medicines